
Unicommerce joins hands with Eat Better to enhance e-commerce operations and accelerate deliveries
Known for blending traditional food wisdom with modern nutritional needs, Eat Better Co has quickly gained traction among health-conscious consumers. Following its spotlight moment on Shark Tank India , the brand is now focused on expanding its direct-to-consumer (D2C) footprint. The adoption of Unicommerce's Uniware platform plays a key role in that strategy.
Through Uniware's advanced multi-channel order management and warehouse management systems, Eat Better Co can manage orders across its website, marketplaces, and quick commerce platforms from a single unified dashboard. The platform helps automate crucial operations like order fulfillment, inventory updates, and delivery coordination — leading to faster, more accurate shipments and reduced operational costs.
With real-time inventory sync across warehouses, Eat Better Co can now maintain optimal stock levels, minimize stockouts, and address underperforming inventory more effectively. Additionally, Unicommerce's predictive analytics and data-driven insights empower the brand to align product offerings with changing consumer preferences, ultimately improving engagement and retention.
This technology-driven partnership not only boosts Eat Better Co's e-commerce agility but also strengthens its long-term vision of becoming a leading player in India's growing healthy snacking segment.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Upturn
2 hours ago
- Business Upturn
MCX and IEX shares in focus as NSE launches Spot Volume Weighted Average Price Calculator for monthly electricity futures
MCX and IEX shares are in focus today as the National Stock Exchange (NSE) rolled out key enhancements for participants in the Electricity Futures (ELECMBL) contract under the Commodity Derivatives Segment, bringing greater transparency and data-driven trading insights. One of the major upgrades is the Spot Volume Weighted Average Price (VWAP) Calculator for Monthly Electricity Futures. Traders can now see in detail how the VWAP, sourced from PXIL, is calculated. The tool considers market clearing volumes and prices from all three power exchanges — Indian Energy Exchange (IEX), Power Exchange India Limited (PXIL), and Hindustan Power Exchange (HPX) — across all Day-Ahead Market (DAM) segments, including Green, Conventional, and High Price power. The interactive calculator allows users to compute block-wise VWAP, view daily VWAP values, and access a clear, time-block-wise breakup (T01 to T96). This transparency ensures participants understand how daily spot prices are derived. In addition, NSE has enhanced the Get Quote Pages for Monthly Electricity Futures by adding Daily DAM Market Statistics in the 'i' pop-up. Traders can now check total daily volumes across all DAM segments, daily VWAP, moving averages of Daily DDR (MAVG-DDR), and historical DDRs for the same month over the past three years — all without leaving the live market view. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at


Business Upturn
2 hours ago
- Business Upturn
Marksans Pharma's UK subsidiary Relonchem secures marketing authorization from MHRA for Metformin tablets
Marksans Pharma Limited (NSE: MARKSANS, BSE: 524404) announced that its wholly owned UK-based subsidiary, Relonchem Limited, has received Marketing Authorization from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for three key anti-diabetic products. The approvals cover: Metformin Hydrochloride Relonchem 500 mg Prolonged Release Tablets Metformin Hydrochloride Relonchem 750 mg Prolonged Release Tablets Metformin Hydrochloride Relonchem 1000 mg Prolonged Release Tablets Metformin is among the most widely prescribed medications for the treatment of type 2 diabetes, playing a crucial role in blood sugar management. With this authorization, Relonchem will be able to expand its presence in the UK market and further strengthen Marksans Pharma's position in the global anti-diabetic segment. Headquartered in Mumbai, Marksans Pharma operates manufacturing facilities in India, the USA, and the UK, all of which are approved by global regulators including USFDA, UKMHRA, and TGA. The company has a diversified product portfolio spanning cardiovascular, central nervous system, anti-diabetic, pain management, gastroenterology, and anti-allergy therapies. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at


Business Upturn
3 hours ago
- Business Upturn
Kwality Pharma receives product registration for Bleomycin 15 IU per vial in Mexico
Kwality Pharmaceuticals Ltd has announced that it has received registration approval for Bleomycin 15 IU in Mexico, enabling the company to begin sales and distribution in the region. Bleomycin is a widely prescribed oncology medicine, used in the treatment of Hodgkin's lymphoma, testicular cancer, and certain squamous cell carcinomas. The approval marks a significant milestone in Kwality Pharmaceuticals' strategy to expand into highly regulated international markets. With this registration, the company is further reinforcing its global footprint in the oncology segment, offering patients access to advanced and affordable cancer treatments. According to the company, the business potential in Mexico is projected to be around USD 1 million in the first year, with supplies scheduled to commence before the end of Q2 FY26. Highlighting its commitment, Kwality Pharmaceuticals stated that it will continue to expand its oncology portfolio across international markets to make high-quality medicines more accessible worldwide. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at